BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 45.90
-1.39 (-2.94%)
Nov 21, 2025, 3:04 PM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 17.62 billion as of November 21, 2025. Its market cap has increased by 0.11% in one year.
Market Cap
17.62B
Enterprise Value
14.72B
Revenue
3.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
45.90
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 17.62B, an increase of 124.21%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 17.62B | 10.08% |
| Dec 31, 2024 | 16.01B | -18.66% |
| Dec 29, 2023 | 19.68B | -7.14% |
| Dec 30, 2022 | 21.19B | -41.13% |
| Dec 31, 2021 | 35.99B | -29.32% |
| Dec 31, 2020 | 50.92B | 85.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 394.36B |
| WuXi AppTec | 272.52B |
| Shenzhen Mindray Bio-Medical Electronics | 235.96B |
| Sichuan Biokin Pharmaceutical | 154.69B |
| Shanghai United Imaging Healthcare | 109.47B |
| Aier Eye Hospital Group | 108.67B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.30B |
| Yunnan Baiyao Group Co.,Ltd | 99.31B |